ES502026A0 - Un procedimiento para preparar derivados de tetrazolilcuma- rina - Google Patents
Un procedimiento para preparar derivados de tetrazolilcuma- rinaInfo
- Publication number
- ES502026A0 ES502026A0 ES502026A ES502026A ES502026A0 ES 502026 A0 ES502026 A0 ES 502026A0 ES 502026 A ES502026 A ES 502026A ES 502026 A ES502026 A ES 502026A ES 502026 A0 ES502026 A0 ES 502026A0
- Authority
- ES
- Spain
- Prior art keywords
- cuma
- rina
- derivatives
- procedure
- tetrazolyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6206280A JPS56158781A (en) | 1980-05-10 | 1980-05-10 | Tetrazolecoumarin derivative, its preparation and antiallergic agent containing the same as active constitutent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES502026A0 true ES502026A0 (es) | 1982-03-01 |
| ES8202818A1 ES8202818A1 (es) | 1982-03-01 |
Family
ID=13189253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES502026A Expired ES8202818A1 (es) | 1980-05-10 | 1981-05-08 | Un procedimiento para preparar derivados de tetrazolilcuma- rina |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4406908A (es) |
| EP (1) | EP0039913B1 (es) |
| JP (1) | JPS56158781A (es) |
| CA (1) | CA1165321A (es) |
| DE (1) | DE3168442D1 (es) |
| ES (1) | ES8202818A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61137881A (ja) * | 1984-12-10 | 1986-06-25 | Kaken Pharmaceut Co Ltd | クロメン誘導体、その製法およびそれを有効成分とする抗アレルギ−剤 |
| US6090836A (en) * | 1996-02-02 | 2000-07-18 | Merck & Co., Inc. | Benzisoxazole-derived antidiabetic compounds |
| US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
| US6020382A (en) * | 1996-02-02 | 2000-02-01 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
| US5847008A (en) * | 1996-02-02 | 1998-12-08 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
| US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
| US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
| JP2004323392A (ja) * | 2003-04-23 | 2004-11-18 | Toyo Kasei Kogyo Co Ltd | ビテトラゾールアミン化合物の製造方法 |
| GB0316546D0 (en) | 2003-07-15 | 2003-08-20 | Novartis Ag | Process for the manufacture of organic compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1434645A (en) | 1973-10-11 | 1976-05-05 | Beecham Group Ltd | Tetrazole coumarin derivatives |
| GB1548254A (en) * | 1976-05-11 | 1979-07-11 | Fisons Ltd | Chromones fabing an (n-tetrazol-5-yl) carboxamide or a 5-tetrazolyl substituent |
| JPS5576873A (en) * | 1978-11-30 | 1980-06-10 | Kaken Pharmaceut Co Ltd | Coumarin derivative, its preparation, and antiallergic drugs containing it as active constituent |
-
1980
- 1980-05-10 JP JP6206280A patent/JPS56158781A/ja active Pending
-
1981
- 1981-05-05 CA CA000376869A patent/CA1165321A/en not_active Expired
- 1981-05-06 US US06/260,900 patent/US4406908A/en not_active Expired - Fee Related
- 1981-05-07 DE DE8181103485T patent/DE3168442D1/de not_active Expired
- 1981-05-07 EP EP81103485A patent/EP0039913B1/en not_active Expired
- 1981-05-08 ES ES502026A patent/ES8202818A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US4406908A (en) | 1983-09-27 |
| EP0039913A1 (en) | 1981-11-18 |
| EP0039913B1 (en) | 1985-01-23 |
| ES8202818A1 (es) | 1982-03-01 |
| CA1165321A (en) | 1984-04-10 |
| JPS56158781A (en) | 1981-12-07 |
| DE3168442D1 (en) | 1985-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES505373A0 (es) | Un metodo para preparar derivados de fenilpiperazina | |
| AR231533A1 (es) | Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida | |
| ES502565A0 (es) | Un procedimiento para preparar derivados de tetralina | |
| ES500726A0 (es) | Un procedimiento para preparar diaminopiridinas | |
| ES532536A0 (es) | Un procedimiento para preparar un derivado de carbostirilo | |
| ES530024A0 (es) | Un procedimiento para preparar derivados de pirazinona | |
| ES500727A0 (es) | Un procedimiento para preparar imidazo-piridinas | |
| ES528304A0 (es) | Un procedimiento para preparar derivados de pirimidona | |
| ES534297A0 (es) | Un procedimiento para preparar derivados de cefem | |
| ES523419A0 (es) | Un metodo para preparar derivados de 4-hidroxi-2-quinolona | |
| ES503134A0 (es) | Un procedimiento para preparar nuevos compuestos de cefem | |
| ES505498A0 (es) | Un procedimiento para preparar nuevos compuestos de cefem | |
| ES530016A0 (es) | Un metodo para preparar derivados de 3-metilflavona | |
| ES502026A0 (es) | Un procedimiento para preparar derivados de tetrazolilcuma- rina | |
| ES505656A0 (es) | Un procedimiento para preparar nuevos derivados de antraci- clina | |
| ES507065A0 (es) | Un metodo para preparar derivados de 2-oxoazetidina. | |
| ES519936A0 (es) | Un procedimiento para preparar derivados de pirimidona. | |
| ES534355A0 (es) | Un metodo para preparar derivados de fenotiazina | |
| ES526177A0 (es) | Un procedimiento para preparar derivados de pirimidona | |
| ES506302A0 (es) | Un procedimiento para preparar derivados de tetrahidroiso- quinoleinas | |
| ES500478A0 (es) | Un procedimiento para obtener derivados de biciclooctano | |
| ES506930A0 (es) | Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida. | |
| ES500464A0 (es) | Un procedimiento para preparar 2-halogeno-acetanilidas | |
| ES513399A0 (es) | Un procedimiento para preparar derivados de dialcohilpirazol | |
| ES527738A0 (es) | Un procedimiento para preparar derivados de piridona |